Screener
First Tracks Biotherapeutics Inc TRAX Total Current Assets
Total Current Assets at other companies
Where this comes from
Reported directly by First Tracks Biotherapeutics Inc in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: First Tracks Biotherapeutics Inc’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-224190
| Line item | March 31, 2026 | December 31,2025 |
|---|---|---|
| Cash and cash equivalents | $248,469 | $238,196 |
| Short-term investments | 37,986 | 73,442 |
| Prepaid expenses and other current assets | 2,947 | 4,762 |
| Total current assets | 289,402 | 316,400 |
| Property and equipment, net | 1,174 | 1,370 |
| Operating lease right-of-use assets | — | 12,519 |
| Other long-term assets | — | 256 |
| Total assets | $290,576 | $330,545 |
Item 1. Combined Financial Statements.
FAQ
- What is First Tracks Biotherapeutics Inc's total current assets?
- First Tracks Biotherapeutics Inc (TRAX) reported total current assets of $289.4M in Q1 2026.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about First Tracks Biotherapeutics Inc's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude